Which is more useful to non-obese patients (BMI< 30) undergoing tracheal intubation, T1% of the corrugator supercilii muscle or effect site concentration of rocuronium calculated by iPad application AnestAssist?

2014 ◽  
Vol 31 ◽  
pp. 37
Author(s):  
K. Makito ◽  
M. Sato ◽  
Y. Suzuki ◽  
K. Horiuchi ◽  
A. Haga ◽  
...  
2007 ◽  
Vol 52 (5) ◽  
pp. 521 ◽  
Author(s):  
Hae Kwang Lee ◽  
Byung Hoon Yoo ◽  
Sang Seok Lee ◽  
Yun Hee Lim ◽  
Jun Heum Yon ◽  
...  

2007 ◽  
Vol 53 (5) ◽  
pp. 565 ◽  
Author(s):  
Hong Sik Lee ◽  
Jang-Ho Song ◽  
Helen Ki Shinn ◽  
Jeong Uk Han ◽  
Jong-Kwon Jung ◽  
...  

2017 ◽  
Vol 46 (1) ◽  
pp. 430-439
Author(s):  
Tae Kyong Kim ◽  
Deok Man Hong ◽  
Seo Hee Lee ◽  
Hyesun Paik ◽  
Se Hee Min ◽  
...  

Objective To investigate the effect-site concentration of remifentanil required to blunt haemodynamic responses during tracheal intubation with a single-lumen tube (SLT) or a double-lumen tube (DLT). Methods Patients scheduled for thoracic surgery requiring one-lung ventilation were randomly allocated to either the SLT or DLT group. All patients received a target-controlled infusion of propofol and a predetermined concentration of remifentanil. Haemodynamic parameters during intubation were recorded. The effect-site concentration of remifentanil was determined using a delayed up-and-down sequential allocation method. Results A total of 92 patients were enrolled in the study. The effective effect-site concentrations of remifentanil required to blunt haemodynamic responses in 50% of patients (EC50) estimated by isotonic regression with bootstrapping was higher in the DLT than the SLT group (8.5 ng/ml [95% confidence interval (CI) 8.0–9.5 ng/ml] versus 6.5 ng/ml [95% CI 5.6–6.7 ng/ml], respectively). Similarly, the effective effect-site concentrations of remifentanil in 95% of patients in the DLT group was higher than the SLT group (9.9 ng/ml [95% CI 9.8–10.0 ng/ml] versus 7.0 ng/ml [95% CI 6.9–7.0 ng/ml], respectively). Conclusions This study demonstrated that a DLT requires a 30% higher EC50 of remifentanil than does an SLT to blunt haemodynamic responses during tracheal intubation when combined with a target-controlled infusion of propofol. Trial registration Clinicaltrials.gov identifier: NCT01542099.


2011 ◽  
Vol 23 (5) ◽  
pp. 379-383 ◽  
Author(s):  
Jeong Uk Han ◽  
Sangyun Cho ◽  
Woo Jae Jeon ◽  
Jong Hoon Yeom ◽  
Woo Jong Shin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document